Posttranscriptional regulation of myosin heavy chain expression in the heart by triiodothyronine

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 2 57-2, 2005, Pages

  Danzi, Sara ^a   Klein, Irwin ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Actinomycin D; Gene transcription; Heterogeneous nuclear RNA; Myocardium; RNA stability; Thyroid hormone

Indexed keywords

COMPLEMENTARY RNA; DACTINOMYCIN; HETEROGENEOUS NUCLEAR RNA; LIOTHYRONINE; MESSENGER RNA; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; MYOSIN III; NUCLEAR RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART; HYPOTHYROIDISM; IN VIVO STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

ANIMALS; DACTINOMYCIN; GENE EXPRESSION; HEART; HYPOTHYROIDISM; MALE; MYOSIN HEAVY CHAINS; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, ANTISENSE; RNA, HETEROGENEOUS NUCLEAR; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRIIODOTHYRONINE;

EID: 12344322279     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00896.2004     Document Type: Article

References (42)

1. Akker SA, Smith PJ, and Chew SL. Nuclear post-transcriptional control of gene expression. J Mol Endocrinol 27: 123-131, 2001.
2. Balkman C, Ojamaa K, and Klein I. Time course of the in vivo effects of thyroid hormone on cardiac gene expression. Endocrinology 130: 2001-2006, 1992.
3. Boheler KR, Chassagne C, Martin X, Wisnewsky C, and Schwartz K. Cardiac expressions of α- and β-myosin heavy chains and sarcomeric α-actins are regulated through transcriptional mechanisms. Results from nuclear run-on assays in isolated rat cardiac nuclei. J Biol Chem 267: 12979-12985, 1992.
4. Brent G. The molecular basis of thyroid hormone action. N Engl J Med 331: 847-854, 1994.
5. Cuadrado A, Bernal J, and Munoz A. Identification of the mammalian homolog of the splicing regulator Suppressor-of-white-apricot as a thyroid hormone regulated gene. Mol Brain Res 71: 332-340, 1999.
6. Cuadrado A, Navarro-Yubero C, Furneaux H, and Munoz A. Neuronal HuD gene encoding a mRNA stability regulator is transcriptionally repressed by thyroid hormone. J Neurochem 86: 763-773, 2003.
7. Danzi S and Klein I. Thyroid hormone-regulated cardiac gene expression and cardiovascular disease. Thyroid 12: 467-472, 2002.
8. Danzi S, Ojamaa K, and Klein I. Triiodothyronine-mediated myosin heavy chain gene transcription in the heart. Am J Physiol Heart Circ Physiol 284: H2255-H2262, 2003.
9. Dillmann WH. Biochemical basis of thyroid hormone action in the heart. Am J Med 88: 626-630, 1990.
10. Edwards JG, Bahl JJ, Flink IL, Cheng SY, and Morkin E. Thyroid hormone influences β-myosin heavy chain (βMHC) expression. Biochem Biophys Res Commun 199: 1482-1488, 1994.
11. Everett AW, Sinha AM, Umeda PK, Jakovcic S, Rabinowitz M, and Zak R. Regulation of myosin synthesis by thyroid hormone: relative change in the α- and β-myosin heavy chain mRNA levels in rabbit heart. Biochemistry 23: 1596-1599, 1984.
12. Haddad F, Bodell PW, Qin AX, Giger JM, and Baldwin KM. Role of antisense RNA in coordinating cardiac myosin heavy chain gene switching. J Biol Chem 278: 37132-37138, 2003.
13. Hu X and Lazar MA. Transcriptional repression by nuclear hormone receptors. Trends Endocrinol Metab 11: 6-10, 2000.
14. Ikeda M, Rhee M, and Chin WW. Thyroid hormone receptor monomer, homodimer, and heterodimer (with retinoid-X receptor) contact different nucleotide sequences in thyroid hormone response elements. Endocrinology 135: 1628-1638, 1994.
15. Ito M and Roeder RG. The TRAP/SMCC/mediator complex and thyroid hormone function. Trends Endocrinol Metab 12: 127-134, 2001.
16. Izumo S, Lompre AM, Matsuoka R, Koren G, Schwartz K, Nadal-Ginard B, and Mahdavi V. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest 79: 970-977, 1987.
17. Klein I and Hong C. Effects of thyroid hormone on the cardiac size and myosin content of the heterotopically transplanted rat heart. J Clin Invest 77: 1694-1698, 1986.
18. Klein I and Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 344: 501-509, 2001.
19. Leinwand LA, Fournier RE, Nadal-Ginard B, and Shows TB. Multigene family for sarcomeric myosin heavy chain in mouse and human DNA: localization on a single chromosome. Science 221: 766-769, 1983.
20. Liu D and Waxman DJ. Post-transcriptional regulation of hepatic NADPH-cytochrome P450 reductase by thyroid hormone: independent effects on poly(A) tail length and mRNA stability. Mol Pharmacol 61: 1089-1096, 2002.
21. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, and Bristow MR. Changes in gene expression in the intact human heart. Downregulation of α-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 100: 2315-2324, 1997.
22. Luther H, Haase H, Hohaus A, Beckmann Reich J, and Morano I. Characterization of naturally occurring myosin heavy chain antisense mRNA in rat heart. J Cell Biochem 70: 110-120, 1998.
23. Mahdavi V, Chambers AP, and Nadal-Ginard B. Cardiac α- and β-myosin heavy chain genes are organized in tandem. Proc Natl Acad Sci USA 81: 2626-2630, 1984.
24. Mahdavi V, Strehler EE, Periasamy M, Wieczorek DF, Izumo S, and Nadal-Ginard B. Sarcomeric myosin heavy chain gene family: organization and pattern of expression. Med Sci Sports Exerc 18: 299-308, 1986.
25. Morkin E. Control of cardiac myosin heavy chain gene expression. Microsc Res Tech 50: 522-531, 2000.
26. Nakao K, Minobe W, Roden R, Bristow MR, and Leinwand LA. Myosin heavy chain gene expression in human heart failure. J Clin Invest 100: 2362-2370, 1997.
27. Ojamaa K, Klemperer JD, MacGilvray SS, Klein I, and Samarel A. Thyroid hormone and hemodynamic regulation of β-myosin heavy chain promoter in the heart. Endocrinology 137: 802-808, 1996.
28. Ojamaa K, Petrie JF, Balkman C, Hong C, and Klein I. Posttranscriptional modification of myosin heavy-chain gene expression in the hypertrophied rat myocardium. Proc Natl Acad Sci USA 91: 3468-3472, 1994.
29. Parmacek MS, Magid NM, Lesch M, Decker RS, and Samarel AM. Cardiac protein synthesis and degradation during thyroxine-induced left ventricular hypertrophy. Am J Physiol Cell Physiol 251: C727-C736, 1986.
30. i and contractile activity. Am J Physiol Cell Physiol 273: C394-C403, 1997.
31. Reiser PJ, Portman MA, Ning XH, and Schomisch Moravec C. Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am J Physiol Heart Circ Physiol 280: H1814-H1820, 2001.
32. Sachs LM and Shi Y. Targeted chromatin binding and histone acetylation in vivo by thyroid hormone receptor during amphibian development. Proc Natl Acad Sci USA 97: 13138-13143, 2000.
33. Sadoshima J, Jahn L, Takahashi T, Kulik TJ, and Izumo S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J Biol Chem 267: 10551-10560, 1992.
34. Shimuzu N, Prior G, Umeda PK, and Zak R. Cis-acting elements responsible for muscle-specific expression of the myosin heavy chain β gene. Nucleic Acids Res 20: 1793-1799, 1992.
35. Sindhwani R, Ismail-Beigi F, and Leinwand LA. Post-transcriptional regulation of rat α cardiac myosin heavy chain gene expression. J Biol Chem 269: 3272-3276, 1994.
36. Sobell HM. Actinomycin and DNA transcription. Proc Natl Acad Sci USA 82: 5328-5331, 1985.
37. Staton JM and Leedman PJ. Posttranscriptional regulation of thyrotropin β-subunit messenger ribonucleic acid by thyroid hormone in murine thyrotrope tumor cells: a conserved mechanism across species. Endocrinology 139: 1093-1100, 1998.
38. Tagami T, Gu WX, Peairs PT, West BL, and Jameson JL. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators. Mol Endocrinol 12: 1888-1902, 1998.
39. 3 receptors. Cell 65: 1255-1266, 1991.
40. Wilkinson MF and Shyu A. Multifunctional regulatory proteins that control gene expression in both the nucleus and the cytoplasm. Bioessays 23: 775-787, 2001.
41. 3 and evidence for an upstream enhancer. Am J Physiol Cell Physiol 276: C883-C891, 1999.
42. Xu L, Glass CK, and Rosenfeld MG. Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 9: 140-147, 1999.